入门知识

    阿里巴巴赴港上市,上市前一天交易阿里巴巴股票

    15th January, 2022

      有消息称,在线零售商巨头阿里巴巴(Alibaba)要重返香港上市,预计在11月底或12月初上市,拟筹集100亿至150亿美元资金。在过去十年中,阿里巴巴以令人印象深刻的销售和盈利增长而闻名,年增长率超过20%。在本月的11.11 光棍节,仅第一个小时就创造了超过100亿美元的销售额。 值得说的就是,在阿里巴巴赴港上市交易的前一天,您还是可以通过辉立暗盘提前买入阿里巴巴的股...

    更多

    小米即将IPO 那些你不能错过的讯息

    15th January, 2022

      小米公司即将在港交所提交上市,有可能成为阿里巴巴之后,全球最大的科技企业IPO。   新加坡的投资者应该如何申请小米IPO ?   只需联系您的经纪人(broker),就能申请小米IPO。但是,投资者需要一次性申购新股至少20万新币。   如果您错过了小米IPO申请,不用担心,在小...

    更多

    申购香港IPO | 2018年可能在香港上市的股票

    15th January, 2022

      小米 据外媒报道,中国智能手机制造商小米公司正与投资银行洽谈股票首度公开发行(IPO)事宜,寻求估值至少500亿美元。据悉,小米2017年收入较其原定目标高出18%,今年利润至少有望达到10亿美元,2018年收入料将达到20亿美元,小米公司的一名发言人证实小米2017年收入将超过150亿美元的收入目标。报道称,香港是最有可能的上市地点,但不排除在纽约上市,也不能确保公...

    更多

    购买港股的过程中,你可知道有些“老千股”碰不得?(上)

    15th January, 2022

      前言 2017年有那么一天,你可记得,香港多只股票开始集体闪崩,场边堪称壮观,而其中多为令投资者深恶痛绝的著名老千股。而香港证监会发言人表示,当天股价大幅下挫的股票多有与不同公司和上市券商存在多重关联、持股集中度高、成交量小、流通股少等特点。这些特点容易导致股价极度波动和市场失当行为。其实大多数就是我们俗称的老千股。不论引起暴跌的导火索是什么,作为投资者,如何辨别老千股,在投资购...

    更多

    2017年港股表现回顾

    15th January, 2022

      前言 本文为港股市场投资报告系列第二篇文章,将回顾港股市场2017年的表现。旨在为想要了解和进入港股市场的投资者们提供更多的参考。   一、全球主要市场股指和恒生指数表现 2017年全球主要市场指数中,香港恒生指数领跑全球,纳斯达克指数位列第2名,涨幅第3的是道琼斯指数,韩国综合指数处于第4名。下图为2017年全球主要股指表现:   ...

    更多

    中文团队手把手教你在新加坡投资港股

    15th January, 2022

      前言 本文为港股市场投资报告系列的第一篇文章,本旨在为想要了解和进入港股市场的投资者们提供更多的参考。本文将对港股市场的交易基础知识做一个全面的概述。在本系列之后的文章中将会更加详细地为投资者解析港股市场的表现回顾与投资机会。 港股市场概述 不同于大陆A股市场有上海和深圳两个市场,香港只有一个交易所,为香港交易及结算所有限公司,简称“香港交易所...

    更多

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com